Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Scottsdale, Arizona, United States
Stephen Johnson, MDAvailable - Uci Health
Orange, California, United States
Namita Goyal, MDAvailable - University of California, San Francisco
San Francisco, California, United States
Jill Goslinga, MD, MPHAvailable - Hospital for Special Care
New Britain, Connecticut, United States
Kevin Felice, DOAvailable - Nova Southeastern University
Davie, Florida, United States
Eduardo Locatelli, MD, MPHAvailable - Mayo Clinic
Jacksonville, Florida, United States
Bjorn Oskarsson, MDAvailable - Augusta University
Augusta, Georgia, United States
Benjamin Barnes, MDAvailable - Indiana University - Iu Health Neuroscience Center
Indianapolis, Indiana, United States
Cynthia Bodkin, MDAvailable - Hennepin Healthcare Research Institute
Minneapolis, Minnesota, United States
Samuel Maiser, MDAvailable - Mayo Clinic
Rochester, Minnesota, United States
Nathan Staff, MD, PhDAvailable - Suny Upstate Medical University
Syracuse, New York, United States
Eufrosina Young, MDAvailable - Duke University
Durham, North Carolina, United States
Richard Bedlack, MD, PhDAvailable - Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Alison Walsh, MDAvailable - Semmes Murphey Foundation
Memphis, Tennessee, United States
Tulio Bertorini, MDAvailable - University of Virginia
Charlottesville, Virginia, United States
Matthew Elliott, MDAvailable
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 12 Mar 2026
- Registered enrollment
- —
- Registry id
- NCT06743776
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.